欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1616/001
药品名称
Emtricitabina + Tenofovir Zentiva
活性成分
emtricitabine 200.0 mg
tenofovir 300.0 mg
剂型
Film-coated tablet
上市许可持有人
Sanofi - Produtos Farmacêuticos, Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Czechia (CZ)
Germany (DE)
Emtricitabin/Tenofovirdisoproxilfumarat Zentiva 200 mg/245 mg Filmtabletten
United Kingdom (Northern Ireland) (XI)
France (FR)
Estonia (EE)
EMTRICITABINE/TENOFOVIR ZENTIVA
许可日期
2017/03/08
最近更新日期
2024/08/19
药物ATC编码
J05AR03 tenofovir disoproxil and emtricitabine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR Summary
|
605102_20170608_PAR_GBB
Date of last change:2024/09/06
Final Product Information
|
Emtricitabine_tenofovir SmPC_LAB_PIL_170308 cl
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase